REGN logo
Regeneron Pharmaceuticals
WA
Based on Analyst Price Targets

Innovative Therapies And Critical Market Expansions Fuel Biotech Growth

US$1.16k
FV
9.9% undervalued intrinsic discount
8.46%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
about 9 hours agoauthor updated this narrative